Clinical performance measures: The changing status of peritoneal dialysis

Citation
Mj. Flanigan et al., Clinical performance measures: The changing status of peritoneal dialysis, KIDNEY INT, 60(6), 2001, pp. 2377-2384
Citations number
32
Categorie Soggetti
Urology & Nephrology","da verificare
Journal title
KIDNEY INTERNATIONAL
ISSN journal
00852538 → ACNP
Volume
60
Issue
6
Year of publication
2001
Pages
2377 - 2384
Database
ISI
SICI code
0085-2538(200112)60:6<2377:CPMTCS>2.0.ZU;2-W
Abstract
Background. The Peritoneal Dialysis-Clinical Performance Measures Project ( PD-CPM) characterizes peritoneal dialysis within the U.S. Current survey re sults are reported and compared to those of previous years. Methods. Prevalence data from random national samples of adult peritoneal d ialysis (PD) patients participating in the United States End-Stage Renal Di sease (ESRD) program have been collected annually since 1995. Results. In 1995, 79% of the respondents used continuous ambulatory periton eal dialysis (CAPD) rather than automated peritoneal dialysis (APD). The me an hematocrit (Hct) of PD patients was 32% and only 66% of individuals had a measurement of dialysis adequacy reported. The mean weekly Kt/V-urea (wKt /V) and weekly creatinine clearance (wC(Cr)) reported for CAPD patients in 1995 were 1.9 and 67 L/1.73 m(2)/week, respectively. In 2000 the median age of PD patients was 55 years and 63% were white. The leading cause of ESRD was diabetes mellitus (34%) and 54% of adult PD patients performed some for m of APD rather than CAPD. Age, sex, size, hematocrit, peritoneal permeabil ity, dialysis adequacy, residual renal function and nutritional indices did not differ between APD and CAPD patients. The mean hemoglobin (Hb) for the 2000 PD-CPM population was 11.6 +/- 1.4 g/dL (mean +/- 1 SD) and 11% of pa tients had an average Hb below 10 g/dL. The average serum albumin was 3.5 /- 0.5 g/dL by the bromcresol green method and 56% of subjects had an avera ge serum albumin equal to or above 3.5 g/dL (or 3.2 g/dL by bromcresol purp le). In 2000 85% of patients had a dialysis adequacy measurement reported a nd the mean calculated wKt/V and wC(Cr) were 2.3 +/- 0.6 and 72.7 +/- 24.9 liters/1.73 m(2)/week for CAPD patients and 2.3 0.6 and 71.6 +/- 25.1 L/1.7 3 m(2)/week for APD patients. PD subjects had a mean body weight of 76 +/- 19 kg and body mass index (BMI) of 27.5 +/- 6.4 kg/m(2). The protein equiva lent of nitrogen appearance (nPNA) of these patients was 0.95 +/- 0.31 g/kg /day, their normalized creatinine appearance rate (nCAR) equaled 17 +/- 6.5 mg/kg/day, resulting in a percent lean body mass (%LBM) of 64 +/- 17% of a ctual body weight. Serum albumin correlated in a positive fashion with BMI, nPNA, nCAR and %LBM, but not with wC(Cr),. Conclusions. The majority of indicator variables monitored by the PD-CPM ha ve improved since 1995. PD patients have higher hemoglobins and a greater p roportion of patients meet the criteria for adequate dialysis. Serum albumi n values, however, remain marginal and unchanged over the five-year project . Furthermore, serum albumin values fail to correlate with the intensity of renal replacement therapy and are not strongly correlated with alternative estimates of nutritional status.